Introduction
Summary
In 2022, an estimated 660 000 women were diagnosed with cervical cancer worldwide and about 350 000 women died from the disease. The main cause of cervical cancer is persistent infection with high-risk types of human papillomavirus (HPV), an extremely common family of viruses that are transmitted through sexual contact. Vaccines exist that protect against high-risk HPV types, and screening programmes can detect signs of disease at an early stage, allowing for effective treatment and management of the condition. This means that cervical cancer should be one of the most preventable and treatable forms of cancer. In many high-income countries, this is the case. High incidence rates and high mortality rates of cervical cancer occur mainly (~90% for both) in low- and middle-income countries.
News & Events
News & Events
News
Impact of knowledge of HPV positivity on cervical cytology performance in Latin America
Read More
08.01.2025
Press Releases
Press Releases
Press Release
New research highlights the potential of single-dose HPV vaccination to advance cervical cancer prevention in low-resource settings
Go to PDF
13.11.2024
Highlights
Highlights
Featured News
Cancer Screening in Five Continents (CanScreen5): a global data repository for breast, cervical, and colorectal cancer screening programmes
Read More
30.04.2024
Videos
Videos
Recording
IARC marks Cervical Cancer Awareness Month 2025
WATCH VIDEO
10.01.2025
Infographics
Infographics
Infographic
IARC marks Cervical Cancer Awareness Month 2025
Read More
10.01.2025
Q&As
Q&As
Cervical Cancer Awareness Month 2021
Questions and Answers (Q&A)
What are the main solutions to address this problem globally?